Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers

Dysregulation of apoptosis plays an important role in carcinogenesis. Therefore, apoptosis-associated genes like the death receptor 4 (DR4, TRAIL-R1) are interesting candidates for modifying the penetrance of breast and ovarian cancer in carriers of BRCA1 and BRCA2 mutations. The DR-4 haplotype 626C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rath, Michèlle Geneviève (VerfasserIn) , Sutter, Christian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 March 2012
In: International journal of cancer
Year: 2012, Jahrgang: 130, Heft: 6, Pages: 1314-1318
ISSN:1097-0215
DOI:10.1002/ijc.26134
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/ijc.26134
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.26134
Volltext
Verfasserangaben:Michelle G. Dick, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold, Raymonda Varon‐Mateeva, Christian Sutter, Dieter Niederacher, Helmut Deissler, Sabine Preisler‐Adams, Karin Kast, Dieter Schäfer, Dorothea Gadzicki, Wolfram Heinritz, Barbara Wappenschmidt and Rita K. Schmutzler

MARC

LEADER 00000caa a2200000 c 4500
001 1585604399
003 DE-627
005 20220815082453.0
007 cr uuu---uuuuu
008 181217s2012 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.26134  |2 doi 
035 |a (DE-627)1585604399 
035 |a (DE-576)515604399 
035 |a (DE-599)BSZ515604399 
035 |a (OCoLC)1341030928 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rath, Michèlle Geneviève  |d 1981-  |e VerfasserIn  |0 (DE-588)1015982379  |0 (DE-627)705465063  |0 (DE-576)351372598  |4 aut 
245 1 0 |a Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers  |c Michelle G. Dick, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold, Raymonda Varon‐Mateeva, Christian Sutter, Dieter Niederacher, Helmut Deissler, Sabine Preisler‐Adams, Karin Kast, Dieter Schäfer, Dorothea Gadzicki, Wolfram Heinritz, Barbara Wappenschmidt and Rita K. Schmutzler 
264 1 |c 15 March 2012 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 11 April 2011 
500 |a Gesehen am 17.12.2018 
520 |a Dysregulation of apoptosis plays an important role in carcinogenesis. Therefore, apoptosis-associated genes like the death receptor 4 (DR4, TRAIL-R1) are interesting candidates for modifying the penetrance of breast and ovarian cancer in carriers of BRCA1 and BRCA2 mutations. The DR-4 haplotype 626C-683C [626C>G, Thr209Arg (rs4871857) and 683A>C, Glu228Ala (rs17088993)] has recently been linked to an increased risk of breast cancer. To evaluate whether DR4 626C>G or DR4 683A>C modifies the risk of breast or ovarian cancer in carriers of BRCA1 and BRCA2 mutations, we undertook a national multicenter study including data of 840 carriers of breast cancer gene (BRCA) mutations. DNA samples were collected from 12 German research centers between 1996 and 2005 and were genotyped by the Taqman allelic discrimination assay. The association between genotypes and incidence of breast or ovarian cancer data was evaluated using a Cox proportional hazards regression model. We found evidence for a significant association of DR4 683A>C with a higher risk for ovarian cancer in carriers of BRCA1 mutations [n = 557, hazard ratio 1.78 (1.24-2.55), p = 0.009]. Our results thus indicate that the DR4 683A>C variant modifies the risk of ovarian cancer in carriers of BRCA1 mutations. 
650 4 |a BRCA 
650 4 |a breast cancer 
650 4 |a death receptor 4 
650 4 |a ovarian cancer 
650 4 |a SNP 
700 1 |a Sutter, Christian  |e VerfasserIn  |0 (DE-588)1067529160  |0 (DE-627)818862068  |0 (DE-576)42671993X  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 130(2012), 6, Seite 1314-1318  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers 
773 1 8 |g volume:130  |g year:2012  |g number:6  |g pages:1314-1318  |g extent:5  |a Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers 
856 4 0 |u http://dx.doi.org/10.1002/ijc.26134  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.26134  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181217 
993 |a Article 
994 |a 2012 
998 |g 1067529160  |a Sutter, Christian  |m 1067529160:Sutter, Christian  |d 910000  |d 911500  |e 910000PS1067529160  |e 911500PS1067529160  |k 0/910000/  |k 1/910000/911500/  |p 7 
999 |a KXP-PPN1585604399  |e 3038463280 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1585604399","language":["eng"],"physDesc":[{"extent":"5 S."}],"person":[{"family":"Rath","given":"Michèlle Geneviève","roleDisplay":"VerfasserIn","role":"aut","display":"Rath, Michèlle Geneviève"},{"family":"Sutter","given":"Christian","display":"Sutter, Christian","role":"aut","roleDisplay":"VerfasserIn"}],"note":["First published: 11 April 2011","Gesehen am 17.12.2018"],"origin":[{"dateIssuedDisp":"15 March 2012","dateIssuedKey":"2012"}],"id":{"doi":["10.1002/ijc.26134"],"eki":["1585604399"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriersInternational journal of cancer","physDesc":[{"extent":"Online-Ressource"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"recId":"269532781","corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"International Union against Cancer"}],"language":["eng"],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"title":[{"title":"International journal of cancer","title_sort":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"pubHistory":["1.1966 -"],"titleAlt":[{"title":"Predictive oncology"}],"id":{"eki":["269532781"],"issn":["1097-0215"],"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"]},"part":{"volume":"130","pages":"1314-1318","text":"130(2012), 6, Seite 1314-1318","issue":"6","year":"2012","extent":"5"},"origin":[{"dateIssuedDisp":"1966-","publisher":"Wiley-Liss","publisherPlace":"Bognor Regis","dateIssuedKey":"1966"}]}],"title":[{"title_sort":"Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers","title":"Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers"}],"name":{"displayForm":["Michelle G. Dick, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold, Raymonda Varon‐Mateeva, Christian Sutter, Dieter Niederacher, Helmut Deissler, Sabine Preisler‐Adams, Karin Kast, Dieter Schäfer, Dorothea Gadzicki, Wolfram Heinritz, Barbara Wappenschmidt and Rita K. Schmutzler"]},"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a RATHMICHELASSOCIATIO1520